- Home
- CELU vs FBLG Comparison
CELU vs FBLG Comparison
Compare CELU & FBLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELU
- FBLG
- Stock Information
- Founded
- CELU 2016
- FBLG 2021
- Country
- CELU United States
- FBLG United States
- Employees
- CELU N/A
- FBLG N/A
- Industry
- CELU Biotechnology: Pharmaceutical Preparations
- FBLG
- Sector
- CELU Health Care
- FBLG
- Exchange
- CELU Nasdaq
- FBLG NYSE
- Market Cap
- CELU 37.7M
- FBLG 37.1M
- IPO Year
- CELU N/A
- FBLG 2024
- Fundamental
- Price
- CELU $2.11
- FBLG $0.73
- Analyst Decision
- CELU
- FBLG Strong Buy
- Analyst Count
- CELU 0
- FBLG 4
- Target Price
- CELU N/A
- FBLG $13.00
- AVG Volume (30 Days)
- CELU 91.2K
- FBLG 191.3K
- Earning Date
- CELU 05-08-2025
- FBLG 05-14-2025
- Dividend Yield
- CELU N/A
- FBLG N/A
- EPS Growth
- CELU N/A
- FBLG N/A
- EPS
- CELU N/A
- FBLG N/A
- Revenue
- CELU $54,220,000.00
- FBLG N/A
- Revenue This Year
- CELU $23.29
- FBLG N/A
- Revenue Next Year
- CELU N/A
- FBLG N/A
- P/E Ratio
- CELU N/A
- FBLG N/A
- Revenue Growth
- CELU 138.11
- FBLG N/A
- 52 Week Low
- CELU $1.00
- FBLG $0.71
- 52 Week High
- CELU $5.22
- FBLG $13.44
- Technical
- Relative Strength Index (RSI)
- CELU 54.10
- FBLG 34.81
- Support Level
- CELU $1.90
- FBLG $0.76
- Resistance Level
- CELU $2.47
- FBLG $0.94
- Average True Range (ATR)
- CELU 0.29
- FBLG 0.08
- MACD
- CELU 0.01
- FBLG -0.01
- Stochastic Oscillator
- CELU 58.25
- FBLG 5.30
About CELU Celularity Inc.
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.
About FBLG FIBROBIOLOGICS INC
FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.